Hubert Schrezenmeier to Kaplan-Meier Estimate
This is a "connection" page, showing publications Hubert Schrezenmeier has written about Kaplan-Meier Estimate.
Connection Strength
0.049
-
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19. J Clin Invest. 2021 10 15; 131(20).
Score: 0.029
-
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation. Haematologica. 2017 04; 102(4):796-803.
Score: 0.021